Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of Aficamten Royalty Pharma Purchases Royalties on Future Sales of Aficamten Cytokinetics to Host Conference Call and Read more…
The Canadian dollar is on a holding pattern ahead of key Canadian and US employment reports later today. Currently, USD/CAD is trading just above the 1.27 line. Nonfarm payrolls could shake up US dollar It Read more…
Featuring Exclusive First NFT Drop From Oscar and Grammy-Winning Composer A.R. Rahman DALLAS, Jan. 7, 2022 /PRNewswire/ — The HBAR Foundation today announced a partnership with Indian composer, producer and musician A.R. Rahman , to Read more…
NEW YORK, Jan. 7, 2022 /PRNewswire/ — SpendEdge has been monitoring the Material Handling Services Market and it is poised to grow by USD 15.81 Billion during 2021-2025. The report offers an up-to-date analysis regarding the Read more…
TORONTO, Jan. 7, 2022 /CNW/ – At McDonald’s Canada we want to show our appreciation and say thanks to those frontline healthcare workers who are working tirelessly to treat those in need, serve our communities Read more…
Seritage Growth Properties (SRG) – Get Seritage Growth Properties Class A Report (the “Company”), a national owner and developer of 170 retail, residential and mixed-use properties, today announced that John Garilli, an existing consultant to Read more…
CHICAGO, Jan. 7, 2022 /PRNewswire/ — According to the new research report the “Autonomous Last Mile Delivery Market by Platform (Aerial Delivery Drones, Ground Delivery Vehicles (Delivery Bots, Self-Driving Vans & Trucks)), Solution, Application, Type, Read more…
NEW YORK, Jan. 7, 2022 /PRNewswire/ — North Atlantic Acquisition Corporation (NAAC) (“NAAC”), a blank check company formed for the purpose of effecting a business combination with a company with global ambition, today announced the Read more…
CAMBRIDGE, Mass., Jan. 7, 2022 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that the first patient has been dosed in ARROS-1, Read more…
IRVING, Texas, Jan. 7, 2022 /PRNewswire/ — Caris Life Sciences ® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today the appointment of Rob Clark as Senior Vice President and Chief Communications Read more…